Evolution of bone mineral density in patients with idiopathic hypercalciuria: a 20-year longitudinal study
- PMID: 32980941
- DOI: 10.1007/s00467-020-04754-6
Evolution of bone mineral density in patients with idiopathic hypercalciuria: a 20-year longitudinal study
Abstract
Background: Several recent studies reported bone mineral density (BMD) reduction in pediatric patients with idiopathic hypercalciuria (IH). This longitudinal study aimed to evaluate BMD evolution in IH patients through three bone densitometry studies conducted over 20 years on average. A second objective was to evaluate urine calcium and citrate excretion during this period.
Methods: Case notes of 34 patients diagnosed with IH at age 7.9 ± 3, alongside results of two bone densitometry studies, performed at 10.5 ± 2.7 (BMD1) and 14.5 ± 2.7 (BMD2) years of age, were reviewed. Patients underwent a third densitometry study in adulthood (BMD3) aged 28.3 ± 2.9. Mean follow-up duration (time-lapse between BMD1 and BMD3) was 17.7 ± 1.4 years.
Results: Statistically significant differences were found between z-BMD3 (- 0.85 ± 1.10) and z-BMD1 (- 1.47 ± 0.99) (P = 0.001) as well as between z-BMD3 and z-BMD2 (- 1.33 ± 1.20) (P = 0.016). At the end of follow-up, z-BMD3 was superior to z-BMD2 in 23 adult patients (67.6%) and lower in 11 patients (5M, 6F; 32.3%). Both men and women showed increased bone mass over time, although such increases were significant only for women. The gradual decrease observed in calcium/creatinine and citrate/creatinine ratios could be related to improvement in osteoblastic activity and especially reduction in osteoclastic activity.
Conclusions: In patients with IH, BMD improves, which may be related especially to female sex, increment of body mass, and reduction in bone resorption. Upon reaching adulthood, urine calcium and citrate excretion tend to decrease so lithogenic risk still remains. The cause of the latter is unknown, although it likely relates to changes in bone activity.
Keywords: Bone mineral density; Hypocitraturia; Idiopathic hypercalciuria; Lithogenic risk.
References
-
- Alhava EM, Juuti M, Karjalainen P (1976) Bone mineral density in patients with urolithiasis. A preliminary report. Scand J Urol Nephrol 10:154–156 - PubMed
-
- Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50:654–658 - PubMed
-
- Messa P, Mioni G, Montanaro D, Adorati M, Antonucci F, Favazza A, Messa M, Enzmann G, Paganin L, Nardini R (1987) About a primitive osseous origin of the so-called ‘renal hypercalciuria’. Contrib Nephrol 58:106–110 - PubMed
-
- Filipponi P, Mannarelli C, Pacifici R, Grossi E, Moretti I, Tini S, Carloni C, Blass A, Morucci P, Hruska KA, Avioli LV (1998) Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria. Calcif Tissue Int 43:61–66
-
- Pacifici R, Rothstein M, Rifas L, Lau KW, Baylink DJ, Avioli LV, Hruska K (1990) Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71:138–145 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
